Observations on the decay of glycated hemoglobin HbA1c in diabetic patients

Experimental and Clinical Endocrinology and Diabetes

Volumn 104, Issue 2, 1996, Pages 102-105

  Rech, M E ^a   Chantelau, E ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Diabetesambulanz MNR Klinik   (Germany)

Author keywords

Diabetes mellitus; Diabetic retinopathy; Metabolic control; Pregnancy

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0029892160     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211430     Document Type: Article

References (20)

1. Aaby Svendsen P, Lauritzen T, Soegaard U, Nerup J: Glycosylated hemoglobin and steady-state mean blood glucose concentration in type-1 (insulin-dependent) diabetes. Diabetologia 23: 403-405, 1982
2. Beach KW: A theoretical model to predict the behavior of glycosylated hemoglobin levels. J Theor Biol 81: 547-561, 1979
3. Chantelau E: Decay of hemoglobin A1c upon return to normoglycaemia (Letter). Diabetologia 35: 191, 1992
4. Chantelau, E, Rech ME: Comment on "The response of GHb to stepwise plasma glucose change over time in diagetic patients" (Letter). Diabetes Care 17: 161, 1994
5. Chew EY, Mills JL, Metzger BE, Remaly NA, Jovanovic-Peterson L, et al: Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy study. Diabetes Care 18: 631-637, 1995
6. Fuhrmann K, Reiher H, Semmler K, Fischer M, Glöckner E: Congential anomalities-etiology, prevention, and prenatal diagnosis. In: L Jovanovic, CM Peterson, K Fuhrmann (Eds) Diabetes and Pregnancy, pp 168-184, Praeger Scientific; New York/Westport/ London, 1985
7. Funatsu H, Yamashita H, Ohashi Y, Ishigaki T: Effect of rapid glycemic control on progression of diabetic retinopathy. Jpn J Opthalmol 36: 356-367, 1992
8. Goldstein DE, Little RR, Wiedmeyer HM, England ID, Rohlfing CL: Glycated hemoglobin estimation in the 1990s: A review of assay methods and clinical interpretation. In: SM Marshall and PD Home (Eds): The Diabetes Annual 8/1994. pp 192-212. Elsevier Science Amsterdam, 1994
9. Gudat U, Chantelau E: Rapid-progressive diabetische Retinopathie bei Stoffwechselnormalisierung - wer ist gefährdet? Z Klin Med 47: 108- 113, 1992
10. Ktorza A, Baigts F, Fumeron F, Rizkalla S, Kinebanyan FM: Effects of slight plasma glucose decrease on glycosylated hemoglobin in healthy subjects during caloric restriction (Letter). New Engl J Med 313: 958-959, 1985
11. Mortensen HB: Glycated hemoglobin. Danish Med Bull 32: 309-328, 1985
12. Mortensen HB, Volund A: Application of a biokinetic model for prediction and assessment of glycated hemoglobins in diabetic patients. Scand J Clin Lab Invest 48: 595-602, 1988
13. Moskalets E, Galstyan G, Starostina E, Antsiferov M, Chantelau E: Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus. J Diab Comp 8: 45-50, 1994
14. Nathan DM, Singer DE, Hurxthal K, Goodson TD: The clinical information value of the glycosylated hemoglobin assay. N Engl J Med 310: 341-346, 1984
15. Pickup JC, Crook MA, Tutt P: Blood glucose and glycated hemoglobin measurement in hospital-Which method? Diabetic Med 10: 402-411, 1993
16. Santiago JV: Response to Dumas (Letter). Diabetes Care 17: 1229, 1994
17. Setiakusuma I, Wiederholt R, Marschall M, Lemke C, Henrichs HR: Beziehungen zwischen HbA1c und klinischen Kriterien der Diabetes-Einstellung. Abstract. Akt Endokr Stoffw 2: 115, 1982
18. Tahara Y Shima K: The response of GHb to stepwise plasma glucose change over time in diabetic patients (Letter). Diabetes Care 16: 1313-1314, 1993
19. Tahara Y, Sima K: Response to Chantelau and Rech (Letter). Diabetes Care 17: 345, 1994
20. Zielke, R. Henrichs HR: Use of the HbA1c determination as longterm parameter in diabetes control. Klin Lab 39: 988-990, 1993